Asymchem completes the listing on the HKEx
2021-12-10

On December 10, 2021, Asymchem was successfully listed on the Hong Kong Stock Exchange, raising a total of approximately HK$7,145 million.

 

Goldman Sachs and CLSA acted as joint sponsors of the offering.

 

CYL & Partners, Cooley and DeHeng Law Offices provided legal services to the issuer in respect of Hong Kong law, US law and PRC law respectively.

 

Latham & Watkins LLP and Jun He Law Offices provided legal services to the joint sponsors in respect of Hong Kong and U.S. law and PRC law respectively.

 

Ernst & Young acted as the auditor and reporting accountant for the offering.

 

Asymchem is a CDMO company that provides one-stop services for the development and production of high-quality new drugs worldwide. Prior to that, Asymchem was listed on the main board of Shenzhen Stock Exchange in 2016.